LivaNova PLC Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
LivaNova PLC Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for LivaNova PLC were recently set by six distinguished experts, with an average mark of $65.00. If it reached this goal, it would represent a potential upside of approximately 17.97% from the previous closing price in April, 2024. The high end is $82.00, and the low is $53.00. If you're considering investing in LIVN stock, it's essential to look at its competitors, too.
17.97% Upside
LivaNova PLC Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, LivaNova PLC's Price has fallen from $33.49 to $0.00 – a 100.00% decrease. In the next year, analysts expect Fair Value to reach $80.16 – an increase of 100.00%. For the next eight years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.86 | Buy/Sell | $118.92 | 18.38% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.26 | Buy/Sell | $70.14 | 9.20% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.25 | Buy/Sell | $92.47 | 20.50% |
| EW Stock Forecast | Edwards Lifesciences Corp | Outperform |
11
|
$88.01 | Buy/Sell | $91.18 | 10.21% |
| 4543 Stock Forecast | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% |
LivaNova PLC Revenue Forecast for 2023 - 2025 - 2030
LivaNova PLC's Revenue has increased by 23.47% In the last three years, going from $934.24M to $1.15B. In the next year, analysts expect Revenue to reach $1.19B – an increase of 3.40%. For the next eight years, the forecast is for Revenue to grow by 25.82%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| FRE Stock Forecast | Fresenius SE & Co. KGaA | Outperform |
18
|
27.18€ | Buy/Sell | 38.63€ | 26.93% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$206.71 | Buy/Sell | $263.46 | 28.20% |
| GETI B Stock Forecast | Getinge AB | Outperform |
18
|
kr229.20 | Buy/Sell | kr226.10 | -0.52% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INSP Stock Forecast | Inspire Medical Systems | Outperform |
6
|
$231.01 | Buy/Sell | $225.45 | 14.71% |
| HAE Stock Forecast | Haemonetics | Outperform |
16
|
$87.66 | Buy/Sell | $70.17 | 19.78% |
| DRW3 Stock Forecast | Drägerwerk AG & Co. KGaA | Outperform |
16
|
49.05€ | Buy/Sell | 54.00€ | 20.29% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AORT Stock Forecast | Artivion | Buy |
12
|
$20.27 | Buy/Sell | $24.15 | 23.33% |
| NYXH Stock Forecast | Nyxoah | Outperform |
4
|
9.34€ | Buy/Sell | 9.65€ | 65.95% |
| BWAY Stock Forecast | BrainsWay | - |
6
|
₪9.54 | Buy/Sell | ₪10.32 | -100.00% |
LivaNova PLC EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, LivaNova PLC's EBITDA has grown from $46.18M to $63.10M – a 36.64% increase. Next year, analysts are expecting EBITDA to reach $243.40M – an increase of 285.74%. Over the next seven years, the forecast is for EBITDA to grow by 360.71%.
LivaNova PLC EBIT Forecast for 2023 - 2025 - 2030
In the last three years, LivaNova PLC's EBIT has grown by 160.94%, rising from $-21.17M to $12.90M. For next year, analysts predict EBIT of $205.80M, which would mean an increase of 1495.35%. Over the next eight years, experts predict that LivaNova PLC's EBIT will grow at a rate of 2536.84%.
LivaNova PLC EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, LivaNova PLC's EPS has fallen from $1.27 to $0.00 – a 100.00% decrease. In the next year, analysts expect EPS to reach $3.04 – an increase of 100.00%. For the next eight years, the forecast is for EPS to grow by 100.00%.
.jpg)